Fourthly, the application of PIK3CA gene mutations in individualized treatment of colorectal cancer is still in its early stages, and more clinical trials and evidence are needed to verify its effectiveness and safety, as well as to optimize its treatment regimens and guiding principles. Here, PIK3CA is linked to colorectal cancer.